## CTSH: Cognizant Technology Solutions  - XLK: Technology

### Executive Summary

VALUE thesis: PEG 1.48 indicates fundamental undervaluation. Quality metrics strong (ROA 10%). Consistent execution (4/4 quarters beat estimates). Caution: momentum weakening (-2.4% MRS), overbought RSI (79).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($80.18)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### News

- **Articles:** 2
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Trumpâ€™s H-1B visa crackdown: Why $100,000 fee will hit TCS, Infosys - explained**
- Source: Times of India | 20251217T070947 | Somewhat-Bearish | Relevance: 92%
- US President Donald Trump's proposed $100,000 fee for H-1B visas is expected to significantly impact Indian IT giants like TCS and Infosys, potentially costing them hundreds of millions of dollars. The substantial levy aims to reduce reliance on foreign workers and could lead to a shift towards offshore recruitment and fewer visa applications. Analysts anticipate a significant reduction in visa applications and increased overseas staff deployment as companies adapt to these new regulations.

**2. Is It Too Late to Consider IBM After Its Big Hybrid Cloud and AI Driven Rally?**
- Source: Simply Wall Street | 20251217T023022 | Neutral | Relevance: 63%
- IBM has seen significant gains, up 37.8% year to date and 215.8% over five years, driven by its hybrid cloud and AI strategy. Despite this rally, traditional valuation metrics suggest IBM is not broadly undervalued, with its DCF indicating it's slightly overvalued. However, a "Fair Ratio" analysis based on P/E suggests it might still be undervalued compared to its fundamentals, presenting a nuanced picture for potential investors.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-08 | UBS | $82 | $78 | +5% |
| 2025-11-21 | William Blair | $0 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-08 | UBS | main | Neutral |
| 2025-11-21 | William Blair | up | Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 18 ($0.00M) |
| Sells | 18 ($2.20M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 52.8% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 12.5% (+0.8%)
- Blackrock Inc.: 10.5% (-0.2%)
- JPMORGAN CHASE & CO: 8.2% (+108.3%)
- State Street Corpora: 5.2% (-0.9%)
- Pzena Investment Man: 3.7% (+1.5%)

### Key Risks

1. Elevated short interest (8.1%): bears positioning against stock.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.48 suggests fair value with growth premium. Forward P/E 14.9x stretched relative to 7% growth. Quality metrics strong (ROA 10%). Balance sheet: strong liquidity (2.4x), low leverage (D/E 0.35), $1.2B free cash flow. Analyst sentiment positive (1 raises, avg +5%). Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $40.9B |
| Beta | 0.97 |
| 52W Range | $65.15 - $90.82 |
| Short Interest | 8.1% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.48 |
| Forward P/E | 14.9 |
| Current P/E | 15.9 |
| YoY Growth | 6.9% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 8.0% to 5.6% (-2.4% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 86th percentile. MRS_5 (-0.0%) diverging from MRS_20 - short-term weakness emerging. AM_20 at 4.9% shows strong absolute momentum above own 20MA. Outperforming sector by 6.1pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). RSI overbought at 79, risk of mean reversion. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: +DBN (Indecision).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.64% (CS: 87) | Strong |
| RSI_14 | 78.6 | Overbought |
| MACD Histogram | 0.15 | Bullish |
| vs SMA20 | 1.049x | Above |
| vs SMA50 | 1.131x | Above |
| vs SMA200 | 1.123x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $83.76
- **Stop Loss:** $80.18 (4.3% risk)
- **Target:** $90.92 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 265
- **Position Value:** $22,196.40
- **Portfolio %:** 22.20%
- **Risk Dollars:** $950.00
- **Risk Per Trade:** 0.95%
- **Modifiers:** L1 95% | L2 100% | Combined 0.95x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 0.95x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with cautious positioning ahead of CPI data. VIX at moderate 16.87 with positive yield curve suggesting stable growth, but narrow breadth at 51.8% indicates selective participation. Banking sector optimism and corporate resilience provide support, though AI volatility creates pockets of uncertainty.*

### Earnings

**Next:** 2026-02-04 (Est: $1.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.30 | $1.39 | +6.7% |
| 2025Q2 | $1.26 | $1.31 | +4.0% |
| 2025Q1 | $1.20 | $1.23 | +2.5% |
| 2024Q4 | $1.13 | $1.21 | +7.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*